Skip to main content

Novo Holdings A/S's Form 4 filing

Arcellx, Inc. (ACLX) · filed Feb 9, 2022

Accession no.
0001209191-22-008145
Filed
Feb 9, 2022
Trade date
Feb 8, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 4 derivative transactions. Open-market purchases total $12.5M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Novo Holdings A/SCIK 000138832510% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 8, 2022COMMON STOCKCConversionAcquired+3,183,545–F1–3,183,545Direct
Feb 8, 2022COMMON STOCKPPurchaseAcquired+833,333$15.00F2+$12,499,9954,016,878Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 8, 2022COMMON STOCKCConversionDisposed−1,550,309–F1–0Direct
Feb 8, 2022COMMON STOCKCConversionDisposed−666,651–F1–0Direct
Feb 8, 2022COMMON STOCKCConversionDisposed−533,389–F1–0Direct
Feb 8, 2022COMMON STOCKCConversionDisposed−433,196–F1–0Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series B-2 Preferred Stock, and Series C Preferred Stock automatically converted into one share of common stock upon the completion of the Issuer's initial public offering. These shares have no expiration date.

Referenced by the price of 1 transaction in Table I and 4 transactions in Table II.

F2

Represents a purchase from the underwriters in the Issuer's initial public offering.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)